Sionna Therapeutics

Forecast & Rating13 analysts currently cover Sionna Therapeutics, with about 15.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.00, about 185.7% upside from the current price of $7.35. Price targets range from $5.00 to $63.00 — a wide spread, showing clear disagreement over just how much Sionna Therapeutics can rise. Historically, about 100.0% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Sionna Therapeutics's outlook. Data as of Sep 15, 2026; for reference only and not investment advice.